Term
- Inactivated by heat
- couples the recognition of antigen by antibodies to a desired biological event
- series of over 30 different serum and membrane proteins (usually inactive)
- do not increase upon immunization |
|
Definition
|
|
Term
- made up of a "cascade" --> activation of one component leads to activation of the next component
- rapid amplification, yet relatively unstable
- synthesized in MHC and Hepatocytes |
|
Definition
|
|
Term
- complement reactions all occur on cell surface
- initial components attach to cell, which activates it |
|
Definition
|
|
Term
- the inactive form of complement components that circulate in blood |
|
Definition
|
|
Term
- abbreviation of complement |
|
Definition
|
|
Term
- usually the smaller fragment of complement
- usually associated with inflammation
- can be anaphylotoxins (stimulate inflammation)
- when bound, release histamine |
|
Definition
|
|
Term
- ions required to activate complement |
|
Definition
|
|
Term
- the bond by which C3b attaches to the pathogen cell surface |
|
Definition
high-energy thioester bond |
|
|
Term
- product of all three complement activation pathways
- results in C3b complement fixation to pathogen surface |
|
Definition
|
|
Term
- first complement pathway to act
- does not require the presence of pre-existing antibodies
- starts in solution and moves to pathogen surface
- produces active C3b |
|
Definition
|
|
Term
- in Alternative Pathway this complex functions as a C3 Convertase
- created from binding of Factor B |
|
Definition
|
|
Term
- breaks the thioester bond of C3 to form iC3 |
|
Definition
|
|
Term
- a protease that cleaves B into Ba and Bb while it is bound to iC3 |
|
Definition
|
|
Term
- feedback from C3b being created by C3bBb in a cycle that proceeds on the pathogen surface that amplifies the response |
|
Definition
Positive Feedback Process |
|
|
Term
- when a pathogen is well-coated by C3b |
|
Definition
|
|
Term
- activated when C3bBb combines with another C3b to form C3b2Bb |
|
Definition
|
|
Term
- stabilizes C3bBb on microbial surface
- works against Factors H and I |
|
Definition
|
|
Term
- makes C3b susceptible to cleavage by Factor I |
|
Definition
|
|
Term
- a lack of this factor depletes the level of C3 in blood, extracellular fluid and lymph --> clearance of infection less effective |
|
Definition
|
|
Term
- after binding to C3b part of convertase --> causes dissociation and inactivation |
|
Definition
|
|
Term
- DAF, MCP, Factor H make up this family |
|
Definition
RCA (regulators of complement activation) |
|
|
Term
- activated after the alternative pathway
- triggered by inflammation--> production of acute-phase proteins |
|
Definition
|
|
Term
- proteins that bind carbohydrates
- MBL is one example that binds Mannose |
|
Definition
|
|
Term
-protein that is responsible for triggering the classical pathway (without antibody binding) |
|
Definition
|
|
Term
- binds to mannose residues of glycoproteins or carbohydrates on the surface of microorganisms
- MASP then binds it
- looks like a bunch of flowers with stems
|
|
Definition
|
|
Term
- number of molecules of MASP-1 and MASP-2 that bind MBL after it binds to microorganisms |
|
Definition
|
|
Term
- cleaves C4 into its 'a' and 'b' fragments in Lectin Pathway |
|
Definition
|
|
Term
- binds to C4b and is then cleaved by MASP-2
- the 'a' fragment stays bound |
|
Definition
|
|
Term
- the C Convertase complex in the Lectin pathway
- can cleave C3 to create a C5 Convertase |
|
Definition
|
|
Term
- the antibodies that activate complement
|
|
Definition
|
|
Term
- due to pentameric structure, the most efficient antibody for complement activation
- only one molecule required to do so |
|
Definition
|
|
Term
- starts when an antibody directed against a protein binds to the surface of that cell or with CRP
- last pathway to respond |
|
Definition
|
|
Term
- first component of complement to bind in classical pathway |
|
Definition
|
|
Term
- functions similarily to MASP-2 in the classical pathway
- looks like an S when free, like a figure 8 when bound to C1q |
|
Definition
|
|
Term
- binding of C1q to the antibody molecules activates this complement |
|
Definition
|
|
Term
- activated by C1r by cleavage
- cleaves C4 to allow C4b to bind to target surface |
|
Definition
|
|
Term
- inhibits activation of C1
- an insufficiency leads to inappropriate release of C2b which can produce leaky vessels and hereditary angioedema |
|
Definition
|
|
Term
- binds C4bC2a and increases the sensitivity of C4b to Factor I |
|
Definition
|
|
Term
- functions similar to C4bp on the surface of cells |
|
Definition
CR1 & MCP (membrane cofactor protein) |
|
|
Term
|
Definition
DAF (decay accelerating factor) |
|
|
Term
- the two C3 Convertases that C3b can bind to |
|
Definition
|
|
Term
At what number C complex does the MAC undergo a conformational shift and insert itself into the membrane? |
|
Definition
|
|
Term
- several of tis complement create a pore in the membrane after C5b678 bores deeper into the membrane |
|
Definition
|
|
Term
- prevent C5b67 from associating with cell membranes |
|
Definition
S Protein
Clusterin
Factor J |
|
|
Term
- prevent recruitment of C9 |
|
Definition
HRF (homologous restriction factor)
CD59 (protectin) |
|
|
Term
-components of complement system are extremely labile
- previous substrate midification
- specific regulatory proteins act on the 3 pathways |
|
Definition
Regulators of the Complement System |
|
|
Term
- important effector of humoral immune response
- particularly can target gram negative bacteria (w/ lysozyme) |
|
Definition
|
|
Term
- macrophages and neutrophils recognize the complement coat which enhances phagocytosis and degradation |
|
Definition
|
|
Term
- vasoactive and allows fluid to move from the blood vessels into the tissues |
|
Definition
|
|
Term
- have receptors for C3b
- carry immune complexes to spleen where they can be phagocytosed and degraded |
|
Definition
|
|
Term
- comes from a lack of necessary comlement components that leads to high levels of immune complexes that can lead to tissue damage
- defects in C1, C4 or C2 |
|
Definition
|
|
Term
- comes from a defect in the anchoring proteins for DAF, HRF and CD59
- host's blood cells become more sensitive to complement which leads to lysing |
|
Definition
Paroxysmal Nocturnal Hemoglobinurea (PNH) |
|
|